Sebela Ireland Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SEBELA IRELAND LTD, and what generic alternatives to SEBELA IRELAND LTD drugs are available?
SEBELA IRELAND LTD has seventeen approved drugs.
There are eleven US patents protecting SEBELA IRELAND LTD drugs.
There are eighty-three patent family members on SEBELA IRELAND LTD drugs in thirty-six countries and two supplementary protection certificates in two countries.
Summary for Sebela Ireland Ltd
| International Patents: | 83 |
| US Patents: | 11 |
| Tradenames: | 12 |
| Ingredients: | 10 |
| NDAs: | 17 |
Drugs and US Patents for Sebela Ireland Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sebela Ireland Ltd | PRAMOSONE | hydrocortisone acetate; pramoxine hydrochloride | CREAM;TOPICAL | 083778-001 | Approved Prior to Jan 1, 1982 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Sebela Ireland Ltd | NAFTIN | naftifine hydrochloride | CREAM;TOPICAL | 019599-002 | Jan 13, 2012 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sebela Ireland Ltd | MICORT-HC | hydrocortisone acetate | CREAM;TOPICAL | 040398-001 | Mar 29, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Sebela Ireland Ltd | NAFTIN | naftifine hydrochloride | CREAM;TOPICAL | 019599-001 | Feb 29, 1988 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Sebela Ireland Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Sebela Ireland Ltd | LOTRONEX | alosetron hydrochloride | TABLET;ORAL | 021107-002 | Dec 23, 2003 | 6,284,770 | ⤷ Sign Up |
| Sebela Ireland Ltd | TRANDATE | labetalol hydrochloride | INJECTABLE;INJECTION | 019425-001 | Dec 31, 1985 | 4,012,444 | ⤷ Sign Up |
| Sebela Ireland Ltd | NAFTIN | naftifine hydrochloride | GEL;TOPICAL | 019356-001 | Jun 18, 1990 | 4,828,251 | ⤷ Sign Up |
| Sebela Ireland Ltd | BRISDELLE | paroxetine mesylate | CAPSULE;ORAL | 204516-001 | Jun 28, 2013 | 5,874,447 | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SEBELA IRELAND LTD drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 0.5 mg and 1 mg | ➤ Subscribe | 2010-12-02 |
| ➤ Subscribe | Capsules | 7.5 mg | ➤ Subscribe | 2014-04-07 |
International Patents for Sebela Ireland Ltd Drugs
Supplementary Protection Certificates for Sebela Ireland Ltd Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0809498 | SPC/GB10/012 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112 |
| 0809498 | 10C0038 | France | ⤷ Sign Up | PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
